凯姆菲罗尔的心脏保护性质:一篇评论
Yusof Kamisah1, Juriyati Jalil2, Nurhanan Murni Yunos3
1Department of Pharmacology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur 56000, Malaysia.
Plants (Basel, Switzerland)
|June 10, 2023
概括
植物类黄胺 (kaempferol) 是一种植物类黄胺,在保护心脏免受损伤方面表现有前途. 本综述详细介绍了其抗氧化和抗炎作用,在各种损伤模型中改善心脏功能.
科学领域:
- 心血管科学 心血管科学
- 药理学 药理学是指药理学的学科.
- 自然产品 自然产品
背景情况:
- 诸如心肌梗塞和心力衰竭等心脏病对全球健康构成重大挑战.
- 具有抗氧化和抗炎性能的生物活性化合物越来越多地因其心脏保护潜力而得到认可.
研究的目的:
- 审查和综合目前关于凯姆菲罗尔心脏保护作用的研究.
- 探索kaempferol对各种心脏损伤模型及其潜在机制的影响.
主要方法:
- 对调查凯姆菲罗尔对心脏损伤影响的研究的文献综述.
- 从各种心脏损伤模型中分析实验数据.
- 综合了与凯姆菲罗尔生物化学和细胞作用相关的发现.
主要成果:
- 在多种心脏损伤模型中,kaempferol显示出显著的心脏保护作用.
- 它可以缓解心肌亡,纤维化,氧化应激和炎症.
- 凯姆菲洛维护心脏中的线粒体功能和平衡.
结论:
- 凯姆费醇具有广泛的心脏保护性质,使其成为心脏病的潜在治疗剂.
- 需要进一步的研究,以充分阐明凯姆菲罗尔心脏保护作用的作用机制.
- 了解这些机制可以指导未来治疗心脏病的治疗策略.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
469
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
469
Cardiopulmonary Resuscitation IV: Pharmacological Management
29
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
29
Coronary Artery Disease IV: Preventive Measures
25
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
25
Heart Failure Drugs: Inotropic Agents
641
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
641
Cardiomyopathy V: Interprofessional Care
18
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
18
Cardiomyopathy II: Dilated Cardiomyopathy
12
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
12


